Ensuring Sustainable Societal Impact of EU-Funded Biomedical Research & Innovation

Global Health Advocates very much welcomes the “Matching Health Needs and Pharmaceutical Research” conference organized by the Austrian Presidency today. With Horizon Europe on the negotiating table, the EU should shift towards a needs-driven R&I agenda that focuses on societal impact to deliver better health and wellbeing for citizens. Ensuring the accessibility and affordability of new health technologies is crucial to meeting health needs and delivering societal impact. In coordination with a range of health NGOs, GHA has developed a proposal for “Access Plans” to encourage beneficiaries of EU R&I funding to think upstream about accessibility challenges. GHA commends the willingness of the Austrian Presidency to focus on this highly important issue and urges political leaders to prioritise societal impact via accessibility in EU R&I.